Abbott India Ltd. Share Price & Stock Analysis

Abbott India Ltd. (BSE: 500488) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹56,531 Cr, it ranks #190 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 63 in Pharmaceuticals. At ₹26,430.00 (as of 16 Nov 2026), the share price is 13.8% below its 52-week high of ₹30,655.00 and 7.2% above its 52-week low of ₹24,650.00. The share price is down 8.1% over one year and down 4.3% over three months.

Key Metrics

Current Price₹26,430.00
Market Cap₹56,531 Cr
BSE Code500488
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio36.3
Return on Equity34.46%
Return on Assets18.28%
52-Week Range₹24,650.00 – ₹30,655.00
1-Year Price Change-8.1%
3-Month Price Change-4.3%
Beta (1Y)-0.17
Dividend Yield1.98%
HeadquartersMumbai, Maharashtra
Websitewww.abbott.co.in

Latest Quarterly Results — Q1 FY27

Revenue₹1,814 Cr
Net Profit₹429 Cr
Net Margin23.6%
EPS (Basic)₹201.66
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Abbott India Ltd. Quarterly Revenue and Profit Trend

Abbott India Ltd. reported revenue of ₹1,814 Cr in Q1 FY27, up 4.3% from ₹1,738 Cr in Q1 FY26 and up 6.1% from ₹1,710 Cr in Q4 FY26. It posted a net profit of ₹429 Cr for the quarter, against a net profit of ₹366 Cr in Q1 FY26 (up 17.1%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹1,605 Cr (Q4 FY25) to ₹1,814 Cr (Q1 FY27). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹1,814 Cr₹429 Cr23.6%
Q4 FY26₹1,710 Cr₹395 Cr23.1%
Q3 FY26₹1,724 Cr₹376 Cr21.8%
Q2 FY26₹1,757 Cr₹415 Cr23.6%
Q1 FY26₹1,738 Cr₹366 Cr21.0%
Q4 FY25₹1,605 Cr₹367 Cr22.9%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 74.99% of Abbott India Ltd.'s shares as of Dec 2018, unchanged from Sept 2017. Delivery averaged 55.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Abbott India Ltd.

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Products and Services

1. Pharmaceuticals-This segment offers pharmaceutical products. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines, consumer health, etc.

Business Segments

1. Pharmaceuticals-100%

Abbott India Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Astrazeneca Pharma India Ltd.₹16,078 Cr85.922.82%₹729 Cr-34.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Abbott India Ltd.?

Abbott India Ltd. is trading at ₹26,430.00, with a market capitalisation of ₹56,531 Cr.

Which sector does Abbott India Ltd. belong to?

Abbott India Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Abbott India Ltd.?

Abbott India Ltd. has a P/E of 36.3 and a return on equity of 34.46%.

What is the stock symbol of Abbott India Ltd.?

Abbott India Ltd. is listed on the BSE under the scrip code 500488.

How has Abbott India Ltd.'s share price moved over the past year?

Abbott India Ltd.'s share price is down 8.1% over one year and down 4.3% over three months. Its 52-week range is ₹24,650.00 to ₹30,655.00.

What were Abbott India Ltd.'s latest quarterly results?

In Q1 FY27, Abbott India Ltd. reported revenue of ₹1,814 Cr and net profit of ₹429 Cr, with basic EPS of ₹201.66 (standalone, parsed from the company's exchange filing).

How have Abbott India Ltd.'s revenue and profit changed over the past year?

Abbott India Ltd. reported revenue of ₹1,814 Cr in Q1 FY27, up 4.3% from ₹1,738 Cr in Q1 FY26 and up 6.1% from ₹1,710 Cr in Q4 FY26.

What is the promoter holding in Abbott India Ltd.?

Promoters held 74.99% of Abbott India Ltd.'s shares as of Dec 2018, unchanged from Sept 2017.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.